HomeCompareADMP vs ORCC

ADMP vs ORCC: Dividend Comparison 2026

ADMP yields 258.06% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADMP wins by $563.88M in total portfolio value
10 years
ADMP
ADMP
● Live price
258.06%
Share price
$0.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$563.90M
Annual income
$319,983,732.54
Full ADMP calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ADMP vs ORCC

📍 ADMP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADMPORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADMP + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADMP pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADMP
Annual income on $10K today (after 15% tax)
$21,935.48/yr
After 10yr DRIP, annual income (after tax)
$271,986,172.66/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ADMP beats the other by $271,986,171.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADMP + ORCC for your $10,000?

ADMP: 50%ORCC: 50%
100% ORCC50/50100% ADMP
Portfolio after 10yr
$281.96M
Annual income
$159,991,866.79/yr
Blended yield
56.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ADMP
Analyst Ratings
3
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-59.7
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADMP buys
0
ORCC buys
0
No recent congressional trades found for ADMP or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADMPORCC
Forward yield258.06%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$563.90M$21.4K
Annual income after 10y$319,983,732.54$1.04
Total dividends collected$538.16M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: ADMP vs ORCC ($10,000, DRIP)

YearADMP PortfolioADMP Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$36,506$25,806.45$11,190$489.61+$25.3KADMP
2$127,109$88,046.91$12,229$256.01+$114.9KADMP
3$422,514$286,507.78$13,216$130.74+$409.3KADMP
4$1,342,148$890,057.94$14,207$66.02+$1.33MADMP
5$4,078,469$2,642,370.06$15,234$33.17+$4.06MADMP
6$11,868,198$7,504,236.72$16,317$16.62+$11.85MADMP
7$33,107,440$20,408,468.42$17,468$8.32+$33.09MADMP
8$88,631,800$53,206,838.59$18,695$4.16+$88.61MADMP
9$227,957,353$133,121,327.57$20,006$2.08+$227.94MADMP
10$563,898,101$319,983,732.54$21,407$1.04+$563.88MADMP

ADMP vs ORCC: Complete Analysis 2026

ADMPStock

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

Full ADMP Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ADMP vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADMP vs SCHDADMP vs JEPIADMP vs OADMP vs KOADMP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.